S1P1

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
scorpion
Family Elder
Posts: 1323
Joined: Wed Nov 05, 2008 3:00 pm

S1P1

Post by scorpion » Thu Jan 27, 2011 9:23 am

Receptos Initiates Clinical Trials for S1P1 Agonist Program, Aimed at Multiple Sclerosis <shortened url>

User avatar
patientx
Family Elder
Posts: 1068
Joined: Wed Sep 10, 2008 2:00 pm

Post by patientx » Thu Jan 27, 2011 3:22 pm

Sounds a lot like Gilenya.

User avatar
dignan
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 2:00 pm

Post by dignan » Thu Jan 27, 2011 8:26 pm

Thanks for the info Scorpion. I agree patientx. I don't know if that's good or bad. On the bright side, it appears to be a worthwhile target. On the other hand, is there any reason to believe this will be better than gilenya?

User avatar
rainer
Family Elder
Posts: 367
Joined: Thu Jan 17, 2008 3:00 pm

Post by rainer » Thu Jan 27, 2011 10:03 pm

If nothing else, maybe it will reduce the price gouging going on.

Post Reply